Placebo News and Research

RSS

Zolmitriptan nasal spray may be safe and effective in treating painful cluster headaches

Zolmitriptan nasal spray, used to treat migraine headaches, also may be safe and effective in treating painful cluster headaches, according to an article posted online today that will appear in the November 2006 print issue of Archives of Neurology.

12 Sep 2006

FDA approves Watson's generic version of Barr's contraceptive pill Seasonale

FDA on Thursday approved Watson Pharmaceuticals' marketing application for its generic version of Barr Laboratories' extended-cycle oral contraceptive Seasonale, Reuters reports.

11 Sep 2006

New drug sorts out premature ejaculation

According the American Urological Association, premature ejaculation affects about 20% of males in the U.S. aged 18-59.

11 Sep 2006

Trial shows H5N1 vaccine safe and effective

A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.

7 Sep 2006

SSRI's developed for premature ejaculation, safe and effective

A selective serotonin reuptake inhibitor (SSRI) developed specifically for the treatment of premature ejaculation is safe and effective for men severely affected by the condition, according to an Article in this week's issue of The Lancet.

7 Sep 2006

Tenecteplase study halted

World Congress of Cardiology 2006 - Thrombolytic Therapy, given during cardiopulmonary resuscitation (CPR) in out-ofhospital cardiac arrests, may be no better than placebo.

6 Sep 2006

Immunotherapy for heart failure

World Congress of Cardiology Report - Heart failure (HF) is a complex, progressive clinical syndrome that can result from any structural or functional cardiac disorder, such as coronary artery disease or hypertension (high blood pressure), which impairs the ability of the heart to function properly as a pump.

5 Sep 2006

VIOXX reduces risk of colorectal polyps

A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.

30 Aug 2006

Celebrex shown to reduce incidence of potentially pre-malignant colorectal polyps

An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.

30 Aug 2006

Cellegy ends phase III microbicide trial in Nigeria

Cellegy Pharmaceuticals on Monday announced that it has ended phase Phase III clinical trials in Nigeria on its microbicide Savvy, the Philadelphia Inquirer reports (Loyd, Philadelphia Inquirer, 8/29).

30 Aug 2006

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

Because of their high content of antioxidants, pomegranate juice is frequently recommended for cancer prevention and overall wellness. While small studies have suggested a role against prostate carcinogenesis, no organized trials have been published until now.

17 Aug 2006

FDA approves Plavix for STEMI heart attacks

The Food and Drug Administration (FDA) today approved the use of Plavix (clopidogrel bisulfate) for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI), who are not going to have coronary artery repair (angioplasty).

17 Aug 2006

First treatment for Hunter disease

An article reporting results from a pivotal clinical trial that helped gain U.S. Food and Drug Administration approval for the first treatment for Hunter disease has been published online by the journal Genetics in Medicine.

16 Aug 2006

Iomai launches study of vaccine patch for travelers' diarrhea

Iomai Corporation has announced that it has begun enrollment of a Phase 2 trial designed to test its vaccine patch for travelers' diarrhea in volunteers traveling to sites in Mexico and Guatemala.

15 Aug 2006

Drug trial fiasco induced immune system overload in patients

The doctors who treated six British men in a trial of a drug in March which went horribly wrong, say they believe the men suffered an immune system overreaction known as a cytokine storm.

15 Aug 2006

Varenicline shown to help 'quit smoking'

A drug recently approved by the U.S. Food and Drug Administration as an aid to smoking cessation appears effective both short- and long-term for smokers trying to quit, according to two reports in the August 14/28 issue of the Archives of Internal Medicine.

14 Aug 2006